Brooke Nichols

Assistant Professor





Huber A, Pascoe S, Nichols B, Long L, Kuchukhidze S, Phiri B, Tchereni T, Rosen S. (2021). Differentiated Service Delivery Models for HIV Treatment in Malawi, South Africa, and Zambia: A Landscape Analysis. Global health, science and practice, 9(2)

Rashid A, Sy KTL, Cabrejas JM, Nichols BE, Bhadelia N, Murray EJ. (2021). A clinician's primer on epidemiology for COVID-19. Med (New York, N.Y.)

Balakasi K, Nichols BE, Mphande M, Stillson C, Khan S, Kalande P, Robson I, Sanena M, Ng'ona K, van Oosterhout JJ, Doi N, Dovel K. (2021). Individual- and Facility-Level Factors Associated with Facility Testing among Men in Malawi: Findings from a Representative Community Survey. Diagnostics (Basel, Switzerland), 11(6)

Sy KTL, White LF, Nichols BE. (2021). Population density and basic reproductive number of COVID-19 across United States counties. PloS one, 16(4)

Claassen CW, Mumba D, Njelesani M, Nyimbili D, Mwango LK, Mwitumwa M, Mubanga E, Mulenga LB, Chisenga T, Nichols BE, Hendrickson C, Chitembo L, Okuku J, O'Bra H. (2021). Initial implementation of PrEP in Zambia: health policy development and service delivery scale-up. BMJ open, 11(7)

Jamieson L, Johnson LF, Matsimela K, Sande LA, d'Elbée M, Majam M, Johnson C, Chidarikire T, Hatzold K, Terris-Prestholt F, Nichols B, Meyer-Rath G. (2021). The cost effectiveness and optimal configuration of HIV self-test distribution in South Africa: a model analysis. BMJ global health, 6(Suppl 4)

Long LC, Rosen S, Nichols B, Larson BA, Ndlovu N, Meyer-Rath G. (2021). Getting resources to those who need them: the evidence we need to budget for underserved populations in sub-Saharan Africa. Journal of the International AIDS Society, (24 Suppl 3)

Nichols BE, Cele R, Lekodeba N, Tukei B, Ngorima-Mabhena N, Tiam A, Maotoe T, Sejana MV, Faturiyele IO, Chasela C, Rosen S, Fatti G. (2021). Economic evaluation of differentiated service delivery models for HIV treatment in Lesotho: costs to providers and patients. Journal of the International AIDS Society, 24(4)

Jo Y, Jamieson L, Edoka I, Long L, Silal S, Pulliam JRC, Moultrie H, Sanne I, Meyer-Rath G, Nichols BE. (2021). Cost-effectiveness of Remdesivir and Dexamethasone for COVID-19 Treatment in South Africa. Open forum infectious diseases, 8(3)

Dovel K, Shaba F, Offorjebe OA, Balakasi K, Nyirenda M, Phiri K, Gupta SK, Wong V, Tseng CH, Nichols BE, Cele R, Lungu E, Masina T, Coates TJ, Hoffman RM. (2020). Effect of facility-based HIV self-testing on uptake of testing among outpatients in Malawi: a cluster-randomised trial. The Lancet. Global health, 8(2)

Nichols K, Girdwood SJ, Inglis A, Ondoa P, Sy KTL, Benade M, Tusiime AB, Kao K, Carmona S, Albert H, Nichols BE. (2020). Bringing Data Analytics to the Design of Optimized Diagnostic Networks in Low- and Middle-Income Countries: Process, Terms and Definitions. Diagnostics (Basel, Switzerland), 11(1)

Nichols BE, Cele R, Jamieson L, Long LC, Siwale Z, Banda P, Moyo C, Rosen S. (2021). Community-based delivery of HIV treatment in Zambia: costs and outcomes. AIDS (London, England), 35(2)

Nichols BE, Kissler SM. (2020). Ending the HIV epidemic in the USA. The lancet. HIV, 7(7)

Nichols BE, Jamieson L, Zhang SRC, Rao GA, Silal S, Pulliam JRC, Sanne I, Meyer-Rath G. (2020). The role of remdesivir in South Africa: preventing COVID-19 deaths through increasing ICU capacity. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America

Hendrickson C, Long L, van de Vijver D, Boucher C, O'Bra H, Claassen CW, Njelesani M, Moyo C, Mumba DB, Subedar H, Mulenga L, Rosen S, Nichols BE. (2020). Novel metric for evaluating pre-exposure prophylaxis programme effectiveness in real-world settings. The lancet. HIV, 7(4)

Long L, Kuchukhidze S, Pascoe S, Nichols BE, Fox MP, Cele R, Govathson C, Huber AN, Flynn D, Rosen S. (2020). Retention in care and viral suppression in differentiated service delivery models for HIV treatment delivery in sub-Saharan Africa: a rapid systematic review. Journal of the International AIDS Society, 23(11)

van de Vijver DA, Nichols BE. (2020). Pre-treatment HIV drug resistance testing cost-effectiveness. EClinicalMedicine, (22)

Nichols BE, Offorjebe OA, Cele R, Shaba F, Balakasi K, Chivwara M, Hoffman RM, Long LC, Rosen S, Dovel K. (2020). Economic evaluation of facility-based HIV self-testing among adult outpatients in Malawi. Journal of the International AIDS Society, 23(9)

Girdwood SJ, Crompton T, Sharma M, Dorward J, Garrett N, Drain PK, Stevens W, Nichols BE. (2020). Cost-effectiveness of adoption strategies for point of care HIV viral load monitoring in South Africa. EClinicalMedicine, (28)

Girdwood SJ, Nichols BE, Moyo C, Crompton T, Chimhamhiwa D, Rosen S. (2019). Optimizing viral load testing access for the last mile: Geospatial cost model for point of care instrument placement. PloS one, 14(8)

Nichols BE, Girdwood SJ, Shibemba A, Sikota S, Gill CJ, Mwananyanda L, Noble L, Stewart-Isherwood L, Scott L, Carmona S, Rosen S, Stevens W. (2020). Cost and Impact of Dried Blood Spot Versus Plasma Separation Card for Scale-up of Viral Load Testing in Resource-limited Settings. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 70(6)

Girdwood SJ, Nichols BE. (2019). Point-of-care assays for early infant diagnosis in Zimbabwe. The lancet. HIV, 6(3)

Popping S, Hullegie SJ, Boerekamps A, Rijnders BJA, de Knegt RJ, Rockstroh JK, Verbon A, Boucher CAB, Nichols BE, van de Vijver DAMC. (2019). Early treatment of acute hepatitis C infection is cost-effective in HIV-infected men-who-have-sex-with-men. PloS one, 14(1)

Long L, Kuchukhidze S, Pascoe S, Nichols B, Cele R, Govathson C, Huber A, Flynn D, Rosen S. (2019). Differentiated models of service delivery for antiretroviral treatment of HIV in sub-Saharan Africa: a rapid review protocol. Systematic reviews, 8(1)

Popping S, Nichols B, Rijnders B, van Kampen J, Verbon A, Boucher C, van de Vijver D. (2019). Targeted HCV core antigen monitoring among HIV-positive men who have sex with men is cost-saving. Journal of virus eradication, 5(4)

Nichols BE, Girdwood SJ, Crompton T, Stewart-Isherwood L, Berrie L, Chimhamhiwa D, Moyo C, Kuehnle J, Stevens W, Rosen S, . (2019). Monitoring viral load for the last mile: what will it cost?. Journal of the International AIDS Society, 22(9)

van Vliet MM, Hendrickson C, Nichols BE, Boucher CA, Peters RP, van de Vijver DA. (2019). Epidemiological impact and cost-effectiveness of providing long-acting pre-exposure prophylaxis to injectable contraceptive users for HIV prevention in South Africa: a modelling study. Journal of the International AIDS Society, 22(12)

van de Vijver DAMC, Richter AK, Boucher CAB, Gunsenheimer-Bartmeyer B, Kollan C, Nichols BE, Spinner CD, Wasem J, Schewe K, Neumann A. (2019). Cost-effectiveness and budget effect of pre-exposure prophylaxis for HIV-1 prevention in Germany from 2018 to 2058. Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin, 24(7)

Nichols BE, Girdwood SJ, Crompton T, Stewart-Isherwood L, Berrie L, Chimhamhiwa D, Moyo C, Kuehnle J, Stevens W, Rosen S, . (2018). Impact of a borderless sample transport network for scaling up viral load monitoring: results of a geospatial optimization model for Zambia. Journal of the International AIDS Society, 21(12)

If you’d like to update your profile, please email modifications to

This site is registered on as a development site.